Results 1 to 10 of about 3,525 (160)
Saudi Pharmaceutical Journal, 2020 Aim: Medicinal plants act as an alternative source of anti-diabetic agents. Recently, Danzhi Jiangtang capsule (DJC) has been clinically used for treatment of diabetes, but the effect of DJC on diabetic macroangiopathy remained unclear. The present study
Liangzhen You
exaly +4 more sources
Cardiovascular Diabetology, 2022 Background Dimethylarginine dimethylaminohydrolase (DDAH) 1 maintains the bioavailability of nitric oxide by degrading asymmetric dimethylarginine (ADMA).
Shiyun Wang +7 more
doaj +2 more sources
Journal of Diabetes Research, 2020 Objective. To investigate the association of the serum adiponectin level with the intima media thickness of the dorsalis pedis artery (D-IMT) and macroangiopathy in type 2 diabetes (T2DM). Methods.
Tao Chen +3 more
doaj +2 more sources
The early diagnostic value of serum renalase level in diabetic kidney disease and diabetic macroangiopathy: a retrospective case–control study [PDF]
Therapeutic Advances in Chronic DiseaseBackground: Diabetic kidney disease (DKD) is a severe complication of diabetes mellitus and is associated with an increased risk of end-stage renal disease (ESRD) and cardiovascular events.
Li Jin +5 more
doaj +2 more sources
MicroRNAs in diabetic macroangiopathy [PDF]
Cardiovascular DiabetologyDiabetic macroangiopathy is a leading cause of diabetes-related mortality worldwide. Both genetic and environmental factors, through a multitude of underlying molecular mechanisms, contribute to the pathogenesis of diabetic macroangiopathy.
Guocheng Rao +5 more
doaj +2 more sources
Application of interpretable machine learning algorithms to predict macroangiopathy risk in Chinese patients with type 2 diabetes mellitus [PDF]
Scientific ReportsMacrovascular complications are leading causes of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM), yet early diagnosis of cardiovascular disease (CVD) in this population remains clinically challenging.
Ningjie Zhang +10 more
doaj +2 more sources
Disturbance of gut microbiota in diabetes related macroangiopathy: Evidence from the gut bacteriome and mycobiome [PDF]
iScienceSummary: Diabetes related macroangiopathy (DMA) is a major complication of type 2 diabetes (T2D), impacting both morbidity and mortality. This study characterized the gut bacteriome and mycobiome in 179 adults, including 58 with DMA, 71 with T2D, and 50 ...
Xiaoling Gou +14 more
doaj +2 more sources
Diabetic macroangiopathy [PDF]
Терапевтический архив, 2019 Diabetes mellitus represents a significant medico - social problem for health care around the world. The main reason for an invalidism and a mortality of patients with diabetes mellitus are the lesions of heart and vessels united in the concept "diabetic
A F Verbovoy +2 more
doaj +1 more source
Cardiovascular diseases in youth patients with glucose metabolism impairment
Arterial Hypertension, 2021 Glucose metabolism disorders in adolescent patients have a diverse background. The most common cause is type 1 diabetes. Persistently elevated blood glucose initiates many processes that lead to blood vessel and nerve damage.
Aleksandra Pilśniak +2 more
doaj +1 more source
The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease. [PDF]
PLoS ONE, 2016 Fibroblast growth factor 23 (FGF23) regulates mineral homeostasis. In developed renal dysfunction, FGF23 levels increase to maintain the phosphate excretion capacity. However, in diabetic patients with early-stage renal impairment, the FGF23 elevation is
Hodaka Yamada +6 more
doaj +1 more source